BCL2 and glioblastoma: Our results show that LXR623 up‐regulates the expression of the pro‐apoptotic Bcl‐2 family member, Noxa, in glioblastoma, colon cancer, and melanoma cell lines (Fig 3A and Appendix Fig S3B).